NovaDigm Consulting Group
↗Rockville, Maryland, USA
NovaDigm Consulting Group (NCG) is a specialized biopharmaceutical management consulting firm providing strategic, operational, and fractional leadership services to the life sciences industry. The firm focuses on drug discovery, clinical development, and biologics manufacturing, often serving as the management vehicle for advanced clinical assets.
NCG is closely associated with the development of the NDV-3A vaccine, a first-in-class 'cross-kingdom' immunotherapeutic designed to protect against both fungal (Candida) and bacterial (Staphylococcus aureus) infections. The firm manages the strategic direction and partnership efforts for this Phase 3-ready asset, which has demonstrated significant efficacy in treating recurrent vulvovaginal candidiasis (RVVC).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Vaccines and Immunotherapeutics
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$10M
Founded:2009
Ownership:private
Status:operating
FUNDING
Stage:Late Stage (Asset Management)
Total Raised:$60M+
Investors:Domain Associates, RusnanoMedInvest (RMI), Lundquist Institute (LA BioMed)
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (Phase 3 Ready)
Modalities:Recombinant Protein, Vaccine, Immunotherapy
Active Trials:1
Trial Phases:Phase 1: 2 | Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:US Department of Defense (DoD), National Institutes of Health (NIH), Lundquist Institute
COMPETITION
Position:Niche Player
Competitors:Mycovia Pharmaceuticals, Scynexis, Pfizer (Vaccine Division), GSK
LEADERSHIP
Key Executives:
Per Lindell - Managing Director
Scientific Founders:John E. Edwards, Jr., M.D., Michael R. Yeaman, Ph.D.
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NovaDigm Consulting Group. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.